Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy.

ABSTRACT: Preliminary evidence supports the notion that COVID-19 patients may have an increased susceptibility to develop venous thromboembolism (VTE). However, the magnitude of this association still needs to be defined. Furthermore, clinical predictors of thrombogenesis, and the relationship with the inflammatory status are currently unknown. On this basis, we conducted a retrospective, observational study on 259 consecutive COVID-19 patients admitted to an academic tertiary referral hospital in Northern Italy between March 19th and April 6th, 2020. Records of COVID-19 patients with a definite VTE event were reviewed for demographic information, co-morbidities, risk factors for VTE, laboratory tests, and anticoagulation treatment. Twenty-five cases among 259 COVID-19 patients developed VTE (9.6%),

SUBMITTER: Melazzini F 

PROVIDER: S-EPMC7648897 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature